160 related articles for article (PubMed ID: 36581166)
1. Mangosteen for malignancy prevention and intervention: Current evidence, molecular mechanisms, and future perspectives.
Kalick LS; Khan HA; Maung E; Baez Y; Atkinson AN; Wallace CE; Day F; Delgadillo BE; Mondal A; Watanapokasin R; Barbalho SM; Bishayee A
Pharmacol Res; 2023 Feb; 188():106630. PubMed ID: 36581166
[TBL] [Abstract][Full Text] [Related]
2. Medicinal properties of mangosteen (Garcinia mangostana).
Pedraza-Chaverri J; Cárdenas-Rodríguez N; Orozco-Ibarra M; Pérez-Rojas JM
Food Chem Toxicol; 2008 Oct; 46(10):3227-39. PubMed ID: 18725264
[TBL] [Abstract][Full Text] [Related]
3. New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines.
Mohamed GA; Al-Abd AM; El-Halawany AM; Abdallah HM; Ibrahim SRM
J Ethnopharmacol; 2017 Feb; 198():302-312. PubMed ID: 28108382
[TBL] [Abstract][Full Text] [Related]
4. The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones.
Nauman MC; Johnson JJ
Pharmacol Res; 2022 Jan; 175():106032. PubMed ID: 34896543
[TBL] [Abstract][Full Text] [Related]
5. Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update.
Ovalle-Magallanes B; Eugenio-Pérez D; Pedraza-Chaverri J
Food Chem Toxicol; 2017 Nov; 109(Pt 1):102-122. PubMed ID: 28842267
[TBL] [Abstract][Full Text] [Related]
6. Validation of LC for the determination of alpha-mangostin in mangosteen peel extract: a tool for quality assessment of Garcinia mangostana L.
Yodhnu S; Sirikatitham A; Wattanapiromsakul C
J Chromatogr Sci; 2009 Mar; 47(3):185-9. PubMed ID: 19298703
[TBL] [Abstract][Full Text] [Related]
7. Distribution of major xanthones in the pericarp, aril, and yellow gum of mangosteen (Garcinia mangostana linn.) fruit and their contribution to antioxidative activity.
Sukatta U; Takenaka M; Ono H; Okadome H; Sotome I; Nanayama K; Thanapase W; Isobe S
Biosci Biotechnol Biochem; 2013; 77(5):984-7. PubMed ID: 23649258
[TBL] [Abstract][Full Text] [Related]
8. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence.
Gutierrez-Orozco F; Failla ML
Nutrients; 2013 Aug; 5(8):3163-83. PubMed ID: 23945675
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Mangostin-Rich Extracts from Mangosteen Pericarp: Optimization of Green Extraction Protocol and Evaluation of Biological Activity.
Ghasemzadeh A; Jaafar HZE; Baghdadi A; Tayebi-Meigooni A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30044450
[TBL] [Abstract][Full Text] [Related]
10. Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana.
Verma N; Pandit S; Kumar A; Yadav G; Giri SK; Lahiri D; Kari ZA; Prasad R; KanuPriya
Appl Biochem Biotechnol; 2022 Oct; 194(10):4724-4744. PubMed ID: 35852758
[TBL] [Abstract][Full Text] [Related]
11. New insights into the anti-obesity activity of xanthones from Garcinia mangostana.
Liu QY; Wang YT; Lin LG
Food Funct; 2015 Feb; 6(2):383-93. PubMed ID: 25520256
[TBL] [Abstract][Full Text] [Related]
12. Garcinia mangostana L. fruits and derived food supplements: Identification and quantitative determination of bioactive xanthones by NMR analysis.
Masullo M; Cerulli A; Cannavacciuolo C; Kılınç H; Pizza C; Piacente S
J Pharm Biomed Anal; 2022 Sep; 218():114835. PubMed ID: 35659659
[TBL] [Abstract][Full Text] [Related]
13. Xanthones from mangosteen (Garcinia mangostana): multi-targeting pharmacological properties.
Jindarat S
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S196-201. PubMed ID: 25518194
[TBL] [Abstract][Full Text] [Related]
14. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.
Do HTT; Cho J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867357
[TBL] [Abstract][Full Text] [Related]
15. Bioaccessibility, biotransformation, and transport of alpha-mangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco-2 human intestinal cells.
Bumrungpert A; Kalpravidh RW; Suksamrarn S; Chaivisuthangkura A; Chitchumroonchokchai C; Failla ML
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S54-61. PubMed ID: 19415666
[TBL] [Abstract][Full Text] [Related]
16. Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: caspase-dependent apoptosis induction in vitro and in mice.
Watanapokasin R; Jarinthanan F; Jerusalmi A; Suksamrarn S; Nakamura Y; Sukseree S; Uthaisang-Tanethpongtamb W; Ratananukul P; Sano T
Appl Biochem Biotechnol; 2010 Oct; 162(4):1080-94. PubMed ID: 20101528
[TBL] [Abstract][Full Text] [Related]
17. Rind from Purple Mangosteen (
John OD; Mouatt P; Panchal SK; Brown L
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499382
[TBL] [Abstract][Full Text] [Related]
18. Identification and Pharmacokinetics of Quinone Reductase 2 Inhibitors after Oral Administration of
Liang X; Hu Y; Li J; Chang AK; Tao X; Li Y; Liu W; Pi K; Yuan J; Jiang Z
J Agric Food Chem; 2020 Oct; 68(43):11975-11986. PubMed ID: 33054205
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats.
Li L; Han AR; Kinghorn AD; Frye RF; Derendorf H; Butterweck V
Planta Med; 2013 May; 79(8):646-53. PubMed ID: 23673465
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CHOP accentuates the apoptotic effect of α-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells.
Li G; Petiwala SM; Nonn L; Johnson JJ
Biochem Biophys Res Commun; 2014 Oct; 453(1):75-80. PubMed ID: 25261723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
